Read More

Pandemic Fallout: 6 Mental Health Stocks To Watch

One of the most devastating long-term impacts of the COVID-19 pandemic may be the toll it has taken on people’s mental health. The next global health crisis may be related to mental health issues such as anxiety and depression, and companies that are focused on mental health could be well-positioned to capitalize on the opportunity.

ACHC

Read More

Why This MindMed Analyst Is Bullish: ‘One Of The Most Diverse Pipelines In Psychedelics’

Mind Medicine (MindMed) Inc (NASDAQ: MNMD) shares traded higher by 3.3% on Monday after one analyst initiated bullish coverage of the psychedelics stock. The Analyst: Maxim analyst Jason McCarthy initiated coverage of MindMed with a Buy rating and $6 price target.

MNMD